Papertis

Stay current without searching the literature.

Built for physicians.

Already a member? Sign in

Searching, done for you

~650 papers screened weekly

Only your topics

You choose among 204

Only what matters

Selected for evidence and impact

Up to date, effortlessly

One email, every Monday

Exceptional findings

When a paper is truly practice-changing, you hear from us the same day.

Blinatumomab replaces chemotherapy in pediatric ALL

Example · NEJM phase 3: 4-year event-free survival 83% vs 70%.

Choose your plan

Start free. Upgrade when you're ready.

All plans free until 31 December 2026.

No card required.

Essential

€2.99/month

Stay current in your specialty.

  • ✓3 topics of your choice
  • ✓The best papers in your topics, every Monday
  • ✓Ongoing clinical trials
Get started
Most popular

Complete

€5.99/month

Your whole field, at a glance.

  • ✓Unlimited topics
  • ✓Every new paper in your topics: the best in your digest, the rest in your dashboard
  • ✓Retraction and correction alerts
  • ✓Ongoing clinical trials
Get started

Stay updated on your topics.

Start free

Informational only — not a substitute for clinical judgment, official guidelines, or individual patient assessment.